Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653405 · ClinicalTrials.gov registry record · NA
Improving Anticoagulation Control in VISN 1
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,260,576
- Enrollment target
NCT01653405: Completed NA study, sponsored by VA Office of Research and Development.
NCT01653405 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,260,576 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01653405, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,260,576 participants
- Enrollment target
Study Summary
Over 100,000 VHA patients receive anticoagulants (blood thinners) each year to prevent blood clots (including strokes). Too much anticoagulation increases the risk of serious or even fatal bleeding, and too little anticoagulation fails to protect the patient against blood clots. VHA anticoagulation clinics vary widely on how much time their patients spend in the therapeutic range, the range within which they are protected from clots but not at excessive risk of bleeding. Anticoagulation clinics can improve anticoagulation control by following several relatively simple procedures, including following-up promptly when patients are out of range and focusing on educating and supporting patients with poor control. In this study, the investigators will promote these practices at the anticoagulation clinics of the New England VA region, with a goal of improving anticoagulation control.
Interventions
- OTHER Multifaceted behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,260,576 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2016-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01653405
The ClinicalTrials.gov registry entry for NCT01653405 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,260,576 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multifaceted behavioral intervention is the first listed.
NCT01653405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01653405 about?
NCT01653405 is a clinical study titled "Improving Anticoagulation Control in VISN 1". Over 100,000 VHA patients receive anticoagulants (blood thinners) each year to prevent blood clots (including strokes). Too much anticoagulation increases the risk of serious or even fatal bleeding, and too little anticoagulation fails to protect the patient against blood clots. VHA anticoagulation ...
What is the current status of trial NCT01653405?
This trial is currently completed. It is a NA study. The enrollment target is 1,260,576 participants. The study started on 2014-10-01. Estimated completion is 2016-09-30.
What interventions are being tested in trial NCT01653405?
The interventions under investigation include: Multifaceted behavioral intervention (OTHER).
Who is sponsoring clinical trial NCT01653405?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.